Growth inhibitory effects of liposome-associated 1-O-octadecyl-2-O- methyl-sn-glycero-3-phosphocholine

Lipids

Volumn 32, Issue 10, 1997, Pages 1045-1054

  Peters, Andrew C ^a   Ahmad, Imran ^a   Janoff, Andrew S ^a   Pushkareva, Marina Y ^a   Mayhew, Eric ^a  

^a Liposome Company Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; COLCHICINE; DOXORUBICIN; EDELFOSINE; LIPOSOME; PACLITAXEL; PHOSPHORYLCHOLINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CELL SURVIVAL; DOSE RESPONSE; GROWTH INHIBITION; HEMOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID ANALYSIS; MULTIDRUG RESISTANCE;

ANIMALS; CALCIUM; CELL DIVISION; DNA FRAGMENTATION; DRUG RESISTANCE, NEOPLASM; HEMOLYSIS; HUMANS; LIPOSOMES; MICE; NEOPLASMS; PHOSPHOLIPID ETHERS; TUMOR CELLS, CULTURED;

EID: 0030856813     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-997-0135-8     Document Type: Article

References (35)

1. Houlihan, W.J., Lohmeyer, M., Workman, P., and Cheon, S.H. (1995) Phospholipid Antitumor Agents, Med. Res. Rev. 15, 157-223.
2. Brachwitz, H., and Vollgraf, C. (1995) Analogs of Alkyllysophospholipids: Chemistry, Effects on the Molecular Level and Their Consequences for Normal and Malignant Cells, Pharmac. Ther. 66, 39-82.
3. Van Blitterswijk, W.J., Hilkmann, H., and Storme, G.A. (1987) Accumulation of an Alkyl Lysophospholipid in Tumor Cell Membranes Affects Membrane Fluidity and Tumor Cell Invasion, Lipids 22, 820-823.
4. Kelley, E.E., Modest, E.J., and Burns, C.P. (1993) Unidirectional Membrane Uptake of the Ether Lipid Antineoplastic Agent Edelfosine by L1210 Cells, Biochem. Pharmacol. 45, 2435-2439.
5. Levitzki, A. (1994) Signal-Transduction Therapy, Eur. J. Biochem. 226, 1-13.
6. Powis, G. (1994) Signalling Pathways as Targets for Anticancer Drug Development, Pharmac. Ther. 62, 57-95.
7. Powis, G. (1994) Recent Advances in the Development of Anticancer Drugs That Act Against Signalling Pathways, Tumori 80, 69-87.
8. Villereal, M.L., and Byron, K.L. (1992) Calcium Signals in Growth Factor Signal Transduction, Rev. Physiol. Biochem. Pharmacol. 119, 67-121.
9. ++] Signaling by Antitumor Ether Lipid Analogues, Cancer Res. 50, 4458-4462.
10. Berridge, M.J. (1993) Inositol Trisphosphate and Calcium Signaling, Nature 361, 315-325.
11. Lohmeyer, M., and Workman, P. (1993) The Role of Intracellular Free Calcium Mobilization in the Mechanism of Action of Antitumour Ether Lipids SRI 62-834 and ET18-OMe, Biochem. Pharmacol. 45, 77-86.
12. 2+ Concentration in a Normal and Breast Cancer Cell Line, Anticancer Res. 14, 1549-1556.
13. 3 Inhibits Nuclear Factor-κB Activation by 12-O-Tetradecanoylphorbol-13-acetate But Not by Tumor Necrosis Factor-α or Interleukin 1α, Cancer Res. 55, 4844-4849.
14. Boggs, K.P., Rock, C.O., and Jackowski, S. (1995) Lysophosphatidylcholine Attenuates the Cytotoxic Effects of the Antineoplastic Phospholipid 1-O-Octadecyl-2-O-methyl-rac-glycero-3-phosphocholine, J. Biol. Chem. 270, 11612-11618.
15. Diomede, L., Colotta, F., Piovani, B., Re, F., Modest, E.J., and Salmona, M. (1993) Induction of Apoptosis in Human Leukemic Cells by the Ether Lipid 1-Octadecyl-2-methyl-rac-glycero-3-phosphocholine. A Possible Basis for Its Selective Action, Int. J. Cancer 53, 124-130.
16. Drings, P., Gunther, I., Gatzemeier, U., Ulbrich, F., Khanavkar, B., Schreml, W., Lorenz, J., Brugger, W., Schick, H.D., Pawel, J.V., and Nordstrom, R. (1992) Final Evaluation of a Phase II Study on the Effects of Edelfosine (an Ether Lipid) in Advanced Non-Small-Cell Bronchogenic Carcinoma, Onkologie 15, 375-382.
17. Sharma, A., Mayhew, E., and Straubinger, R.M. (1993) Antitumor Effect of Taxol-Containing Liposomes in a Taxol-Resistant Murine Tumor Model, Cancer Res. 53, 5877-5881.
18. Vaage, J., Donovan, D., Mayhew, E., Uster, P., and Woodle, M. (1993) Therapy of Mouse Mammary Carcinomas with Vincristine and Doxorubicin Encapsulated in Sterically Stabilized Liposomes, Int. J. Cancer 54, 959-964.
19. Papahadjopoulos, D., Allen, T.M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S.K., Lee, K.-D., Woodle, M.C., Lasic, D.D., Redemann, C., and Martin, F.J. (1991) Sterically Stabilized Liposomes: Improvements in Pharmacokinetics and Antitumor Therapeutic Efficacy, Proc. Natl. Acad. Sci. USA 88, 11460-11464.
20. Perkins, W.R., Dause, R.B., Li, X., Franklin, J.C., Cabral-Lily, D.J., Dank, E.H., Mayhew, E., and Janoff, A.S. (1997) Combination of Antitumor Ether Lipid with Lipids of Complementary Molecular Shape Reduces Its Transfer to RBCs, Biochim. Biophys. Acta 88, 61-68.
21. Mayhew, E., Ahmad, I., Bhatia, S., Dause, R., Filep, J., Janoff, A.S., Kaisheva, E., Perkins, W.R., Zha, Y., and Franklin, J.C. (1997) Stability of Association of 1-O-Octadecyl-2-O-methyl-sn-glycero-3-phosphocholine with Liposomes Is Composition Dependent, Biochim. Biophys. Acta 1329, 139-148 (1997).
22. Szoka, F.C., and Papahadjopoulos, D. (1980) Comparative Properties and Methods of Preparation of Lipid Vesicles (Liposomes), Ann. Rev. Biophys. Bioeng. 9, 467-508.
23. Monks, A., Scudiero, D., Skehan, P., Shoemaker, R., Paull, K., Vistica, D., Hose, C., Langley, J., Cronise, P., Vaigor-Wolff, A., Gray-Goodrich, M., Campbell, H., Mayo, J., and Boyd, M. (1991) Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines, J. Natl. Canc. Inst. 38, 757-766.
24. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J.T., Bokesch, H., Kenney, S., and Boyd, M.R. (1990) New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening, J. Natl. Canc. Inst. 82, 1107-1112.
25. Fujiwara, K., Daniel, L.W., Modest, E.J., and Wallen, C.A. (1994) Relationship of Cell Survival, Drug Dose, and Drug Uptake After 1-O-Octadecyl-2-O-methyl-rac-glycero-3-phosphocholine Treatment, Cancer Chemother. Pharmacol 34, 427-476.
26. 2+ Indicators with Greatly Improved Fluorescence Properties, J. Biol. Chem. 260, 3440-3450.
27. L in the Control of Apoptosis in Murine Myeloma Cells, Cancer Res. 56, 1451-1456.
28. Lohmeyer, M., and Workman, P. (1995) Growth Arrest vs. Direct Cytotoxicity and the Importance of Molecular Structure for the In Vitro Anti-Tumour Activity of Ether Lipids, Brit. J. Cancer 72, 277-286.
29. Lohmeyer, M., and Bittman, R. (1994) Antitumor Ether Lipids and Alkylphosphocholines, Drugs of the Future 19, 1021-1037.
30. Ahmad, I., Filep, J.J., Franklin, J.C., Janoff, A., Masters, G.R., Pattassery, J., Peters, A., Schupsky, J.J., Zha, Y., and Mayhew, E. (1997) Enhanced Therapeutic Effects of Liposome Associated 1-O-Octadecyl-2-O-methyl-sn-glycero-3-phosphocholine, Cancer Res. 57, 1915-1921.
31. Perez-Sala, D., and Mollinedo, F. (1995) Inhibition of N-Linked Glycosylation Induces Early Apoptosis in Human Promyelocytic HL-60 Cells, J. Cell. Physiol. 163, 523-531.
32. Gregoriadis, G. (1995) Engineering Liposomes for Drug Delivery: Progress and Problems, Tibtech 13, 527-537.
33. Janoff, A.S. (1992) Editorial: Lipids, Liposomes, and Rational Drug Design, Lab. Invest. 66, 655-658.
34. Layton, D., Luckenbach, G.A., Andreseen, R., and Munder, P.G. (1980) The Interaction of Liposomes with Cells: The Relation of Cell Specific Toxicity to Lipid Composition, Eur. J. Cancer 16, 1529-1538.
35. Kumar, V.V. (1991) Complementary Molecular Shapes and Additivity of the Packing Parameter of Lipids, Proc. Natl. Acad. Sci. USA 88, 444-448.